echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Amino Acids Research > Evonik 2013 Earnings Report: Increase research and development efforts to achieve future growth strategy

    Evonik 2013 Earnings Report: Increase research and development efforts to achieve future growth strategy

    • Last Update: 2020-06-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    our strategic success - Wintron has maintained solid results despite the tough market conditions
    btKChairman DrInkaiShi said: "We have achieved the company's strategic objective: Evonik has become a specialty chemical listed companyWe have maintained a solid performance in the face of a difficult market environment"
    BTK2013 Operating Results:BTKGroup sales totaled 12.9 billion euros, its own business sales momentum is good
    BTK, adjusted EBITDA of 2 billion euros, mainly affected by price factors, down from last year's very high levelBTKadjusted EBITDA margin of 15.6%, attractiveBT K, research and development investment of 394 million euros, research and development costs of 3.1%BTK 2014 outlook: expected sales slightly increase, adjusted EBITDA between 1.8 billion and 2.1 billion euros
    BTK Essen - Evonik Industries recently announced its 2013 results "Evonik successfully listed on the Frankfurt Stock Exchange and spun off its real estate business last summer, successfully transforming itself into a company focused on specialty chemicals In 2013, the company achieved its growth strategy and successfully completed its first investment projects," said Dr Inkai Shi, chairman of Evonik Industrial Group BTK
      In 2013, the overall economic situation was more severe than expected Despite the increase in sales, the fall in selling prices affected Evonik's operating results "Despite the tough market conditions, our performance has been solid," Mr Inkai said "We will further improve the operational and administrative efficiency of the company and systematically improve cost management." This will enhance the competitiveness of the company and support our profitable growth," he stressed BTK
      Evonik expects sales to increase slightly in 2014 compared to last year (2013: 12.9 billion euros) and adjusted EBITDA to be between 1.8 billion and 2.1 billion euros (2013: 2 billion euros) BTK
      The Group's own business esbusinesss have a strong sales momentum and solid operating results
    BTK 2013, the growth rate of Asia Pacific and North America slowed, affecting end-sector customers in these two key markets, which in turn affected the company's performance The continued weakness in Europe has also had an impact on corporate results Challenging market conditions put pressure on the prices of some key products, resulting in a significant decline in their prices On the other hand, continued high global demand has driven a significant increase in sales, particularly in the second half of 2013 BTK
      In 2013, sales of the Group's own business were stable, down 1% from last year This was mainly due to a 5pc drop in sales and a 4pc rise in sales Add to that other factors including the divestiture of two small businesses in 2012 (which resulted in a 2pc drop in sales) and the exchange rate impact (which resulted in a 1pc drop in sales), with overall sales down 4 per cent to EUR 12.874 billion (2012: EUR 13.365 billion) BTK
      Operating results fell from last year's extremely high level, mainly due to lower prices for certain key products Overall, adjusted EBITDA fell 19% to EUR 2,007 million (2012: EUR 2,467 million), while Adjusted EBIT fell 25% to EUR 1,424 million (2012: EUR 1,887 million) Adjusted EBITDA of 15.6%, the company's earnings level is still quite attractive (2012: 18.5%) " Evonik 2013 Financial Results" to improve research and development efforts to achieve future growth strategy
    "Evonik 2013 Financial Results" to improve research and development efforts to achieve future growth strategy (2) 1 / 2 1 2 the next page we achieved strategic success - despite the difficult market environment, Evonik still maintained a solid performance
    BTK We have maintained a solid performance in the face of a difficult market environment "
    BTK 2013 Operating Results: BTK Group sales totaled 12.9 billion euros, its own business sales momentum is good
    BTK , adjusted EBITDA of 2 billion euros, mainly affected by price factors, down from last year's very high level BTK adjusted EBITDA margin of 15.6%, attractive BT K , research and development investment of 394 million euros, research and development costs of 3.1% BTK 2014 outlook: expected sales slightly increase, adjusted EBITDA between 1.8 billion and 2.1 billion euros
    BTK Essen - Evonik Industries recently announced its 2013 results "Evonik successfully listed on the Frankfurt Stock Exchange and spun off its real estate business last summer, successfully transforming itself into a company focused on specialty chemicals In 2013, the company achieved its growth strategy and successfully completed its first investment projects," said Dr Inkai Shi, chairman of Evonik Industrial Group BTK
      In 2013, the overall economic situation was more severe than expected Despite the increase in sales, the fall in selling prices affected Evonik's operating results "Despite the tough market conditions, our performance has been solid," Mr Inkai said "We will further improve the operational and administrative efficiency of the company and systematically improve cost management." This will enhance the competitiveness of the company and support our profitable growth," he stressed BTK
      Evonik expects sales to increase slightly in 2014 compared to last year (2013: 12.9 billion euros) and adjusted EBITDA to be between 1.8 billion and 2.1 billion euros (2013: 2 billion euros) BTK
      The Group's own business esbusinesss have a strong sales momentum and solid operating results
    BTK 2013, the growth rate of Asia Pacific and North America slowed, affecting end-sector customers in these two key markets, which in turn affected the company's performance The continued weakness in Europe has also had an impact on corporate results Challenging market conditions put pressure on the prices of some key products, resulting in a significant decline in their prices On the other hand, continued high global demand has driven a significant increase in sales, particularly in the second half of 2013 BTK
      In 2013, sales of the Group's own business were stable, down 1% from last year This was mainly due to a 5pc drop in sales and a 4pc rise in sales Add to that other factors including the divestiture of two small businesses in 2012 (which resulted in a 2pc drop in sales) and the exchange rate impact (which resulted in a 1pc drop in sales), with overall sales down 4 per cent to EUR 12.874 billion (2012: EUR 13.365 billion) BTK
      Operating results fell from last year's extremely high level, mainly due to lower prices for certain key products Overall, adjusted EBITDA fell 19% to EUR 2,007 million (2012: EUR 2,467 million), while Adjusted EBIT fell 25% to EUR 1,424 million (2012: EUR 1,887 million) Adjusted EBITDA of 15.6%, the company's earnings level is still quite attractive (2012: 18.5%) shared it on the feed's tweets
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.